Zofran Birth Defect Attorney
Did you take Zofran while pregnant?
Zofran (generic name: ondansetron) is a prescription medication commonly prescribed “off-label” for morning sickness in pregnant women. The FDA (Food and Drug Administration) did not approve Zofran for use during pregnancy, and research shows that pregnant women who take Zofran during the first trimester are 30% more likely to have a child with a birth defect. If your child was exposed to this dangerous drug before birth, contact Stern Law Group for legal guidance.
Dangerous Off-Label Prescriptions
Drug manufacturers introduced Zofran into the United States medical market in 1991. In 2006, consumers had access to generic brands. Since then, Zofran gained momentum as an off-label remedy for morning sickness in pregnant women – even though the FDA didn’t approve it.
Over time, doctors identified a possible connection between these off-label treatments and birth defects. In 2013, a study revealed a 200% increase in cardiovascular birth defects in children who were exposed to Zofran when their mothers took it during the first trimester of pregnancy.
Birth Defect Risks and Zofran
According to researchers, taking Zofran during pregnancy can lead to the following birth defects:
- Heart murmur
- ASD (Atrial septal defect)
- VSD (Ventricular septal defect)
- Kidney defects (malformation or missing)
- Skull deformation
- Limb defects
- Cleft palate
- Cleft lip
- Growth restriction
- Wrongful death
Choose an Award-Winning Law Firm
Stern Law Group has help more than 40,000 clients recover the compensation they needed and deserved. If you suspect that an off-label Zofran prescription caused your child’s birth defect, speak with a member of our legal team today. We have more than 150 years of combined legal experience – let us use it to help you seek rightful compensation for your damages.
Ready to start your case? Fill out our online case evaluation form to learn more about your legal options with our law firm.